Identifying dysfunctional crosstalk of pathways in various regions of Alzheimer's disease brains

BackgroundAlzheimer's disease (AD) is a major neurodegenerative disorder leading to amnesia, cognitive impairment and dementia in the elderly. Usually this type of lesions results from dysfunctional protein cooperations in the biological pathways. In addition, AD progression is known to occur in different brain regions with particular features. Thus identification and analysis of crosstalk among dysregulated pathways as well as identification of their clusters in various diseased brain regions are expected to provide deep insights into the pathogenetic mechanism.ResultsHere we propose a network-based systems biology approach to detect the crosstalks among AD related pathways, as well as their dysfunctions in the six brain regions of AD patients. Through constructing a network of pathways, the relationships among AD pathway and its neighbor pathways are systematically investigated and visually presented by their intersections. We found that the significance degree of pathways related to the fatal disorders and the pathway overlapping strength can indicate the impacts of these neighbored pathways to AD development. Furthermore, the crosstalks among pathways reveal some evidence that the neighbor pathways of AD pathway closely cooperate and play important tasks in the AD progression.ConclusionsOur study identifies the common and distinct features of the dysfunctional crosstalk of pathways in various AD brain regions. The global pathway crosstalk network and the clusters of relevant pathways of AD provide evidence of cooperativity among pathways for potential pathogenesis of the neuron complex disease.

[1]  S. Kasif,et al.  Network-Based Analysis of Affected Biological Processes in Type 2 Diabetes Models , 2007, PLoS genetics.

[2]  Luonan Chen,et al.  Biomolecular Networks: Methods and Applications in Systems Biology , 2009 .

[3]  Jing Zhu,et al.  Edge-based scoring and searching method for identifying condition-responsive protein-protein interaction sub-network , 2007, Bioinform..

[4]  Ian M. Donaldson,et al.  The Biomolecular Interaction Network Database and related tools 2005 update , 2004, Nucleic Acids Res..

[5]  R. Sharan,et al.  Protein networks in disease. , 2008, Genome research.

[6]  Shinichiro Wachi,et al.  Interactome-transcriptome analysis reveals the high centrality of genes differentially expressed in lung cancer tissues , 2005, Bioinform..

[7]  Gabriele Ausiello,et al.  MINT: the Molecular INTeraction database , 2006, Nucleic Acids Res..

[8]  Yoshihiro Yamanishi,et al.  KEGG for linking genomes to life and the environment , 2007, Nucleic Acids Res..

[9]  Benno Schwikowski,et al.  Discovering regulatory and signalling circuits in molecular interaction networks , 2002, ISMB.

[10]  Hongyu Zhao,et al.  Pathway analysis using random forests classification and regression , 2006, Bioinform..

[11]  M. Wolfe.  Presenilin and gamma-secretase: structure meets function. , 2001, Journal of neurochemistry.

[12]  M. Wolfe.  Presenilin and γ‐secretase: structure meets function , 2001 .

[13]  A. Grigoriev.  A relationship between gene expression and protein interactions on the proteome scale: analysis of the bacteriophage T7 and the yeast Saccharomyces cerevisiae. , 2001, Nucleic acids research.

[14]  Richard M. Karp,et al.  Detecting Disease-Specific Dysregulated Pathways Via Analysis of Clinical Expression Profiles , 2008, RECOMB.

[15]  T. Ideker,et al.  Network-based classification of breast cancer metastasis , 2007, Molecular systems biology.

[16]  L. Hood,et al.  Dysregulated gene expression networks in human acute myelogenous leukemia stem cells , 2009, Proceedings of the National Academy of Sciences.

[17]  Martin Vingron,et al.  IntAct: an open source molecular interaction database , 2004, Nucleic Acids Res..

[18]  Hanno Steen,et al.  Development of human protein reference database as an initial platform for approaching systems biology in humans. , 2003, Genome research.

[19]  M. Goedert,et al.  A Century of Alzheimer's Disease , 2006, Science.

[20]  M. Gerstein,et al.  Relating whole-genome expression data with protein-protein interactions. , 2002, Genome research.

[21]  G. Church,et al.  Correlation between transcriptome and interactome mapping data from Saccharomyces cerevisiae , 2001, Nature Genetics.

[22]  Haidong Wang,et al.  Discovering molecular pathways from protein interaction and gene expression data , 2003, ISMB.

[23]  Brad T. Sherman,et al.  Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources , 2008, Nature Protocols.

[24]  M. Ashburner,et al.  Gene Ontology: tool for the unification of biology , 2000, Nature Genetics.

[25]  Mirko Francesconi,et al.  Reconstructing networks of pathways via significance analysis of their intersections , 2008, BMC Bioinformatics.

[26]  Allan Birnbaum,et al.  Combining Independent Tests of Significance , 1954 .

[27]  Sayan Mukherjee,et al.  Modeling Cancer Progression via Pathway Dependencies , 2008, PLoS Comput. Biol..

[28]  R. Tibshirani,et al.  Significance analysis of microarrays applied to the ionizing radiation response , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[29]  J. Trojanowski,et al.  Tau-mediated neurodegeneration in Alzheimer's disease and related disorders , 2007, Nature Reviews Neuroscience.

[30]  Winnie S. Liang,et al.  Alzheimer's disease is associated with reduced expression of energy metabolism genes in posterior cingulate neurons , 2008, Proceedings of the National Academy of Sciences.

[31]  J. Hardy,et al.  The Amyloid Hypothesis of Alzheimer ’ s Disease : Progress and Problems on the Road to Therapeutics , 2009 .

[32]  D. Selkoe.  Alzheimer's disease: genes, proteins, and therapy. , 2001, Physiological reviews.

[33]  Paul A. Bates,et al.  Global topological features of cancer proteins in the human interactome , 2006, Bioinform..

[34]  Hui Lu,et al.  Correlation between gene expression profiles and protein-protein interactions within and across genomes , 2005, Bioinform..

[35]  Pablo Tamayo,et al.  Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[36]  K. Aihara,et al.  Uncovering signal transduction networks from high-throughput data by integer linear programming , 2008, Nucleic acids research.

[37]  V. Lee,et al.  Mechanism of Ca2+ Disruption in Alzheimer's Disease by Presenilin Regulation of InsP3 Receptor Channel Gating , 2008, Neuron.

[38]  Mike Tyers,et al.  BioGRID: a general repository for interaction datasets , 2005, Nucleic Acids Res..

[39]  M. Memo,et al.  Unfolded p53: a potential biomarker for Alzheimer's disease. , 2007, Journal of Alzheimer's disease : JAD.

[40]  Pankaj Agarwal,et al.  A global pathway crosstalk network , 2008, Bioinform..

[41]  Susumu Goto,et al.  The commonality of protein interaction networks determined in neurodegenerative disorders (NDDs) , 2007, Bioinform..

[42]  E. Tobinick,et al.  TNF-alpha modulation for treatment of Alzheimer's disease: a 6-month pilot study. , 2006, MedGenMed : Medscape general medicine.

[43]  Victoria Bolós,et al.  Notch signaling in development and cancer. , 2007, Endocrine reviews.

[44]  D. Selkoe.  Alzheimer's disease. , 2011, Cold Spring Harbor perspectives in biology.